Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Therapeutic options to support septal reduction therapy for hypertrophic cardiomyopathy patients.

Created on 16 Nov 2026

Authors

Stuti Shah, Hesham Sheashaa, Elizabeth Brahier, Nicholas G Smedira, Susan K Keen, Milind Y Desai

Published in

Expert review of cardiovascular therapy. Nov 15, 2026. Epub Nov 15, 2026.

Abstract

Obstructive hypertrophic cardiomyopathy is characterized by dynamic left ventricular outflow tract obstruction that can cause substantial symptoms and morbidity. The expanding range of pharmacologic, surgical, and transcatheter options has made treatment selection increasingly complex.
This narrative review examines conventional medical therapy, cardiac myosin inhibitors, surgical septal myectomy, alcohol septal ablation, and emerging investigational septal reduction strategies. It also discusses patient selection, procedural risks, multimodality imaging, and the importance of experienced hypertrophic cardiomyopathy centers. A targeted narrative search of English-language literature indexed in PubMed was conducted from April through 31 July 2026, considering clinical trials, observational studies, guidelines, and relevant reviews.
Cardiac myosin inhibitors are likely to modify the timing of septal reduction therapy rather than replace it. Future progress will depend on mechanism-based treatment selection, appropriate early referral, rigorous validation of emerging procedures, and integration of advanced imaging and multidisciplinary expertise to match each patient with the most suitable therapy.

PMID:
43035341
Bibliographic data and abstract were imported from PubMed on 16 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement